COMMUNIQUÉS West-GlobeNewswire

Les ambassadeurs Phonak sensibilisent les jeunes à la santé auditive à l’occasion de la Journée mondiale de l’audition
26/02/2026
STÄFA, Suisse, 26 févr. 2026 (GLOBE NEWSWIRE) -- À l’occasion de la Journée mondiale de l’audition, le 3 mars, Phonak , leader mondial des solutions auditives innovantes, lancera une campagne mondiale couvrant trois [...]
Phonak ambassadors spotlight hearing health for the next generation on World Hearing Day
26/02/2026
STÄFA, Switzerland, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Phonak, a global leader in innovative hearing solutions, will mark World Hearing Day on March 3 with a global campaign across three continents, putting youth hearing [...]
Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
26/02/2026
Leiden, the Netherlands, February 26, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the [...]
Sequana Medical Reports Strong US Commercial Progress with Five Centers Completing alfapump® System Implants Since Launch
26/02/2026
Ghent, Belgium, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Leading US liver transplant center completes its first two implantations Mount Sinai Hospital and University of Pennsylvania also complete multiple implantations [...]
Asahi Kasei to Acquire Aicuris to Accelerate Growth in Severe Infectious Diseases
26/02/2026
Wuppertal, Germany, February 26, 2026 - Aicuris Anti-infective Cures AG (“Aicuris”) today announced that it has entered into a definitive agreement under which Asahi Kasei, through its wholly owned U.S. subsidiary [...]
Pulselight to host senior health leaders for panel on ‘efficiency drive’ to reduce NHS waste and duplication
26/02/2026
Former UK Health Minister Lord Bethell and former Deputy Chief Medical Officer Professor Sir Jonathan Van-Tam, join Pulselight for panel on unlocking NHS efficiency LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Pulselight, [...]
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
26/02/2026
$1.3 billion in fourth quarter and $4.2 billion in full year global product net sales, representing 90% year ‑ over ‑ year growth Delivered $1.1 billion in operating income in 2025, marking first year of operating [...]
Idorsia reports strong 2025 results with QUVIVIQ sales more than doubling – further sales growth ahead with multiple pipeline catalysts in 2026
26/02/2026
Ad hoc announcement pursuant to Art. 53 LR Idorsia delivers on its upgraded 2025 guidance , with strong QUVIVIQ sales growth, disciplined investment, and a significantly improved bottom line. Focused investment in [...]
InnoCare Announces Key Developments of Critical Clinical Studies
26/02/2026
BEIJING, Feb. 26, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today key clinical development [...]
Codetta Bio Announces Commercial Availability of Concerto™ System and New Customizable Cytokine and Neuroscience Panels at AGBT 2026
26/02/2026
ORLANDO, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Codetta Bio™, a leader in multi-omic solutions that combine ultrasensitive protein quantification with simultaneous RNA and DNA analysis, today announced major product [...]
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
26/02/2026
Study met primary endpoint (p-value = 0.012) First registrational study to specifically evaluate a targeted treatment for patients living with ocular MG Results support planned Supplemental Biologics License Application [...]
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering
26/02/2026
BALA CYNWYD, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]
Sprout Health GLP-1 Weight Loss in 2026 — Compounded Semaglutide Pricing, FDA Status, and What To Know Before Starting a Telehealth GLP-1 Program
26/02/2026
An Independent Informational Overview Examining Sprout Health's Compounded GLP-1 Telehealth Model, Semaglutide and Tirzepatide Program Costs, FDA Regulatory Classification, and Consumer Verification Considerations for [...]
MindRank Announces First Patient Dosed in Phase III Trial of AI-Designed Oral GLP-1 Receptor Agonist MDR-001
26/02/2026
SHANGHAI, China, Feb. 25, 2026 (GLOBE NEWSWIRE) -- MindRank, a clinical-stage artificial intelligence (AI)-empowered drug discovery company, today announced that the first patient has been dosed in the Phase III [...]
Considering MEDVi Tirzepatide GLP-1 Weight Loss in 2026? Read This Before Enrolling in Any Tirzepatide GLP-1 Telehealth Weight Loss Program
26/02/2026
An independent informational overview of MEDVi's compounded tirzepatide telehealth program, including regulatory classification, platform structure, pricing disclosures, and key consumer verification steps. NEWARK, DE, [...]
Palvella Therapeutics Announces Pricing of Upsized Public Offering
26/02/2026
WAYNE, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat [...]
Considering MEDVi QUAD in 2026? Read This Before Enrolling in Any Compounded ED Telehealth Program
26/02/2026
An informational overview of publicly available disclosures, regulatory context, and verification steps consumers commonly review before starting compounded erectile dysfunction treatment through telehealth. NEWARK, DE [...]
ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
25/02/2026
FY 2025 Total Revenue of $510 Million, Representing 20% Year-Over-Year Growth FY 2025 ASCENIV Revenue Grew to $363 Million, Representing 51% Year-Over-Year Growth FY 2025 Adjusted Net Income ( 1) of $161 Million, [...]
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
25/02/2026
FOSTER CITY, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that members of senior management will be [...]

Pages